Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial Among 1.3 million ...
Messages are not cenetered, and stretch from edge to edge of the screen, even the chat pane on the left cannot be sized up to mitigate this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback